Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells
- PMID: 8301935
- DOI: 10.1038/ki.1993.387
Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells
Abstract
Although hyperlipidemia is a well-recognized complication of the nephrotic syndrome, the precise interaction of human glomerular cells and human lipoproteins, abnormal in lipid and protein composition, has not been clearly defined. This study examines receptor mediated binding, internalization and degradation as well as intracellular cholesterol metabolism of apoB-100 containing LDL and apoB,E containing IDL, isolated from patients with the nephrotic syndrome (N = 6), in human glomerular epithelial cells and skin fibroblasts. In the patients, serum LDL cholesterol level was increased threefold and IDL elevenfold as compared to healthy subjects. IDL of nephrotic patients contained 72% more cholesterol than IDL of healthy controls. No difference in lipid/protein composition was found in the LDL density range. Therefore, nephrotic and control LDL showed identical affinities for receptor mediated binding, internalization and degradation. Furthermore, inhibition of intracellular sterol synthesis and cholesteryl ester formation after incubation with LDL was comparable. In contrast, cholesterol-rich IDL of nephrotic patients was taken up by glomerular epithelial cells with higher affinity than LDL and control IDL, as well as intracellular sterol synthesis was suppressed more effectively than by control IDL. The cholesterol esterification rate of IDL from patients was enhanced 3.5-fold as compared to control IDL. In comparison to fibroblasts, glomerular epithelial cells showed about 15% of the maximal capacity for LDL uptake, but 31% for IDL from nephrotic patients. The data indicate that hypercholesterolemia of nephrotic origin cannot be explained by reduced ligand binding for LDL. ApoE containing IDL, which accumulate in nephrotic patients, were avidly taken up by glomerular epithelial cells via receptor dependent pathway. These lipoproteins could therefore play the predominant role in glomerular lipid accumulation and development of glomerulosclerosis.
Similar articles
-
Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.Miner Electrolyte Metab. 1996;22(1-3):39-46. Miner Electrolyte Metab. 1996. PMID: 8676822
-
Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.J Am Soc Nephrol. 1994 Oct;5(4):1081-90. doi: 10.1681/ASN.V541081. J Am Soc Nephrol. 1994. PMID: 7849247
-
Uptake and metabolism of lipoproteins from patients with diabetes mellitus type II by glomerular epithelial cells.Nephrol Dial Transplant. 1997 Jul;12(7):1336-43. doi: 10.1093/ndt/12.7.1336. Nephrol Dial Transplant. 1997. PMID: 9249767
-
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.Kidney Int. 2016 Jul;90(1):41-52. doi: 10.1016/j.kint.2016.02.026. Epub 2016 Apr 26. Kidney Int. 2016. PMID: 27165836 Free PMC article. Review.
-
Progression of renal failure: role of apolipoprotein B-containing lipoproteins.Kidney Int Suppl. 1997 Dec;63:S98-101. Kidney Int Suppl. 1997. PMID: 9407433 Review.
Cited by
-
Preprocedural Lp(a) level and ApoB/ApoA-Ι ratio and the risk for contrast-induced acute kidney injury in patients undergoing emergency PCI.Lipids Health Dis. 2021 Oct 9;20(1):130. doi: 10.1186/s12944-021-01535-4. Lipids Health Dis. 2021. PMID: 34627286 Free PMC article.
-
Protective effect of eriodictyol against hyperglycemia-induced diabetic nephropathy in rats entails antioxidant and anti-inflammatory effects mediated by activating Nrf2.Saudi Pharm J. 2023 Nov;31(11):101817. doi: 10.1016/j.jsps.2023.101817. Epub 2023 Oct 5. Saudi Pharm J. 2023. PMID: 37915829 Free PMC article.
-
Dehydrozingerone inhibits renal lipotoxicity in high-fat diet-induced obese mice.J Cell Mol Med. 2021 Sep;25(18):8725-8733. doi: 10.1111/jcmm.16828. Epub 2021 Aug 12. J Cell Mol Med. 2021. PMID: 34382326 Free PMC article.
-
Exosomal Bupivacaine: Integrating Nerve Barrier Penetration Capability and Sustained Drug Release for Enhanced Potency in Peripheral Nerve Block and Reduced Toxicity.Adv Funct Mater. 2024 Oct 15;34(42):2406876. doi: 10.1002/adfm.202406876. Epub 2024 Jul 20. Adv Funct Mater. 2024. PMID: 40027274
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous